Skip to main content

Peer Review reports

From: IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway

Original Submission
13 Oct 2017 Submitted Original manuscript
6 Nov 2017 Reviewed Reviewer Report - Qiongyu Hao
15 Nov 2017 Reviewed Reviewer Report - Giuseppina De Petro
13 Dec 2017 Author responded Author comments - Wei-Chieh Huang
Resubmission - Version 2
13 Dec 2017 Submitted Manuscript version 2
12 Apr 2018 Author responded Author comments - Wei-Chieh Huang
Resubmission - Version 3
12 Apr 2018 Submitted Manuscript version 3
27 Apr 2018 Author responded Author comments - Wei-Chieh Huang
Resubmission - Version 4
27 Apr 2018 Submitted Manuscript version 4
12 May 2018 Author responded Author comments - Wei-Chieh Huang
Resubmission - Version 5
12 May 2018 Submitted Manuscript version 5
Publishing
18 May 2018 Editorially accepted
30 May 2018 Article published 10.1186/s12885-018-4529-9

You can find further information about peer review here.

Back to article page